'Tomudex' (raltitrexed) plus 5-fluorouracil: A promising option for the treatment of patients with metastatic colorectal cancer

被引：1
|
作者：
Schwartz, GK
Bertino, J
Kemeny, N
Saltz, L
Kelsen, DK
Tong, W
Barazzuol, J
Lowery, C
Smith, M
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Zeneca Pharmaceut, Wilmington, DE USA
[3] Zeneca Pharmaceut, Alderley Pk, England
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)80666-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
233
引用
收藏
页码：S74 / S74
页数：1
相关论文
共 50 条
  • [31] Clinical trial of low-dose leucovorin plus 5-fluorouracil for patients with metastatic colorectal cancer
    Yamaguchi, Yoshiyuki
    Sawamura, Akihiro
    Minami, Kazuhito
    HEPATO-GASTROENTEROLOGY, 2007, 54 (77) : 1394 - 1397
  • [32] 5-Fluorouracil versus 5-fluorouracil plus alpha-interferon as treatment of metastatic colorectal carcinoma. A randomized study
    Dufour, P
    Husseini, F
    Dreyfus, B
    Cure, H
    Martin, C
    Prevost, G
    Olivier, JP
    Dumas, F
    Duclos, B
    Olivares, R
    Leszler, A
    Bergerat, JP
    Audhuy, B
    Thill, L
    Oberling, F
    ANNALS OF ONCOLOGY, 1996, 7 (06) : 575 - 579
  • [33] TREATMENT OF METASTATIC COLORECTAL CARCINOMA WITH 5-FLUOROURACIL BY MOUTH
    LAHIRI, SR
    BOILEAU, G
    HALL, TC
    CANCER, 1971, 28 (04) : 902 - &
  • [34] COST IMPACT OF ORAL CAPECITABINE COMPARED TO 5-FLUOROURACIL FOR TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER
    Citarella, A.
    Cammarota, S.
    Riegler, S.
    Putignano, D.
    Menditto, E.
    VALUE IN HEALTH, 2010, 13 (07) : A262 - A262
  • [35] Evaluation of relative costs of the cytostatic agents Tomudex(R) and 5-Fluorouracil plus Leucovorin as treatments for advanced colorectal cancer
    Groener, MGH
    vanIneveld, BM
    Byttebier, G
    Rutten, FFH
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : OP11 - OP11
  • [36] An oxaliplatin plus 5-fluorouracil bolus plus folinic acid (BFOL) regimen as first-line treatment in metastatic colorectal cancer patients
    La Verde, Nicla
    Garassino, Marina
    Bareggi, Claudia
    Sburlati, Paola
    Borgonovo, Karen
    Dimaiuta, Mariastella
    Mantica, Cristina
    Perrone, Silvia
    Torri, Valter
    Farina, Gabriella
    TUMORI, 2007, 93 (06) : 557 - 561
  • [37] Adjuvant therapy with raltitrexed in patients with colorectal cancer intolerant of 5-fluorouracil: British Columbia cancer agency experience
    Wilson, Kenneth S.
    Fitzgerald, Catherine A.
    Barnett, Jeff B.
    Gill, Sharlene
    Khoo, Kong E.
    CANCER INVESTIGATION, 2007, 25 (08) : 711 - 714
  • [38] Oxaliplatin plus raltitrexed and leucovorin-modulated 5-fluorouracil i.v. bolus: a salvage regimen for colorectal cancer patients
    P Comella
    R Casaretti
    E Crucitta
    F De Vita
    S Palmeri
    A Avallone
    M Orditura
    L De Lucia
    S Del Prete
    G Catalano
    V Lorusso
    G Comella
    British Journal of Cancer, 2002, 86 : 1871 - 1875
  • [39] Oxaliplatin plus raltitrexed and leucovorin-modulated 5-fluorouracil i.v. bolus: a salvage regimen for colorectal cancer patients
    Comella, P
    Casaretti, R
    Crucitta, E
    De Vita, F
    Palmeri, S
    Avallone, A
    Orditura, M
    De Lucia, L
    Del Prete, S
    Catalano, G
    Lorusso, V
    Comella, G
    BRITISH JOURNAL OF CANCER, 2002, 86 (12) : 1871 - 1875
  • [40] A phase I study of raltitrexed (Tomudex) combined with carmofur in metastatic colorectal cancer
    Österlund, P
    Elomaa, I
    Virkkunen, P
    Joensuu, H
    ONCOLOGY, 2001, 61 (02) : 113 - 119
12345